Psychiatry and Neurology, Neurology · Philadelphia, PA
NPI
1396907143
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
800 Spruce Street
Philadelphia, PA, 19107
Phone (215) 829-6500
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
1,985 services
Medicare patients, 2024
461
Average age 73
Drug cost, 2024
$2.1M
5,133 prescriptions
Company payments, 2025
$6,856
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andres Deik Acosta Madiedo was code 99213 (office e&m - established), 262 times for 202 patients. In total Andres Deik Acosta Madiedo billed 1,985 services in 24 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 262 | 202 | $44.25 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 255 | 207 | $12.39 | $3,160 |
| 99214 Office E&M - Established | Facility | 187 | 165 | $72.96 | $14K |
| 64616 Musculoskeletal | Facility | 102 | 41 | $111.15 | $11K |
| 64642 Musculoskeletal | Facility | 100 | 41 | $69.21 | $6,921 |
| 95983 Electrical Nerve Conductivity | Facility | 82 | 50 | $34.94 | $2,865 |
| 64612 Musculoskeletal | Facility | 64 | 25 | $119.71 | $7,661 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 46 | 42 | $12.31 | $566 |
| 99204 Office E&M - New | Facility | 41 | 41 | $91.84 | $3,765 |
| 64643 Musculoskeletal | Facility | 33 | 16 | $46.94 | $1,549 |
| 95874 Musculoskeletal | Facility | 21 | 14 | $13.25 | $278 |
| 99205 Office E&M - New | Facility | 18 | 18 | $138.92 | $2,500 |
| 99215 Office E&M - Established | Facility | 15 | 15 | $110.84 | $1,663 |
By year: 2022 $88K for 1,889 services; 2023 $79K for 1,481 services; 2024 $73K for 1,985 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andres Deik Acosta Madiedo prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 990 prescriptions and refills. In total Andres Deik Acosta Madiedo wrote 5,133 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 990 | 2,396 | 271 | $52K |
| Clonazepam Generic | 402 | 693 | 94 | $6,308 |
| Rytary Carbidopa/Levodopa | 236 | 415 | 43 | $472K |
| Gocovri Amantadine Hcl | 228 | 242 | 26 | $690K |
| Escitalopram Oxalate Generic | 227 | 507 | 57 | $3,182 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 225 | 552 | 68 | $16K |
| Amantadine Amantadine Hcl | 171 | 435 | 50 | $13K |
| Donepezil Hcl Generic | 168 | 354 | 44 | $1,484 |
| Selegiline Hcl Generic | 157 | 363 | 42 | $17K |
| Gabapentin Generic | 137 | 253 | 30 | $2,447 |
| Rasagiline Mesylate Generic | 132 | 352 | 36 | $23K |
| Quetiapine Fumarate Generic | 111 | 250 | 34 | $2,588 |
| Duloxetine Hcl Generic | 107 | 207 | 18 | $2,795 |
| Entacapone Generic | 100 | 202 | 25 | $20K |
| Neupro Rotigotine | 94 | 153 | 19 | $125K |
Brand drugs: 843 claims; generic drugs: 4,290 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andres Deik Acosta Madiedo $6,856 ($6,856 in general payments such as food, travel and fees) from 6 companies. The largest payer was Amneal Pharmaceuticals LLC with $6,563.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.